Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back

David R. Jayne, MD

University of Cambridge
Cambridge, United Kingdom

David Jayne is Professor of Clinical Autoimmunity at the University of Cambridge, UK, and Director of the Vasculitis and Lupus service at Addenbrookes Hospital Cambridge. He trained at the Universities of Cambridge and London, and in nephrology at Harvard Medical School, Boston, USA. He was a research fellow at Imperial College London and the University of Cambridge and was appointed as a Senior Lecturer in Nephrology at St George’s Hospital London. Since 2001 he has been working in Cambridge where he is an Honorary Consultant Physician at Addenbrookes Hospital.

His research has focused on ANCA associated vasculitis and on the development of clinical trials to optimise current therapies and introduce new agents. Topics have included intravenous immunoglobulin, plasma exchange, mycophenolate mofetil and several newer immunosuppressives including avacopan and rituximab. In parallel, he has investigated newer therapies in SLE and lupus nephritis, including stem cell transplantation, mycophenolate mofetil and many immunomodulators. He is President of the European Vasculitis Society and coordinator of trials and academic meetings. He has published over 600 papers and has chaired or contributed to numerous guideline statements including the EULAR-ERA task force on lupus nephritis and KDIGO guidelines for glomerulonephritis.

Presentation(s):